Clinical Trials Browser

mirdametinib × Dermatologic × Clear all

NCT07237100 2025-11-19

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Phase 2 Recruiting

CNSDermatologic

Melanoma, Neurofibromatoses

NCT06159166 2025-04-23

Mirda

Phase 1/2 Recruiting

CNSDermatologic

NF1